Boothbay Fund Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-10,702
Closed -$63K – 2095
2022
Q3
$63K Sell
10,702
-3,000
-22% -$1.77K ﹤0.01% 2094
2022
Q2
$123K Buy
13,702
+2,500
+22% +$1.39K ﹤0.01% 1931
2022
Q1
$132K Buy
+11,202
New +$6.11K ﹤0.01% 2037

Other funds holding DRTSW

Boothbay Fund Management's DRTSW Position: Q4 2022 in Review

Boothbay Fund Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2022, closing a stake of 10,702 shares — an estimated $63K sold.

Boothbay Fund Management first reported a position in DRTSW in Q1 2022 and held it in 3 quarters. The position peaked at $132K in Q1 2022. 34 funds tracked by Wall St. Rank hold DRTSW as of Q4 2022.

  • Boothbay Fund Management reported no remaining Alpha Tau Medical Warrant position as of Q4 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 10,702 Alpha Tau Medical Warrant shares in Q4 2022, an estimated $63K.
  • Boothbay Fund Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 3 quarters.
  • Boothbay Fund Management's Alpha Tau Medical Warrant position peaked at $132K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.